CORO1A links inflammatory chondrocyte subpopulations to immune microenvironment alterations in osteoarthritis: an integrative multi-omics and single-cell study - Scorecard - MDSpire

CORO1A links inflammatory chondrocyte subpopulations to immune microenvironment alterations in osteoarthritis: an integrative multi-omics and single-cell study

  • By

  • Qiujian Liang

  • Chao Ning

  • Shiyao Gao

  • Dongxin Liu

  • Jinmin Zhao

  • Linke Huang

  • Jun Hou

  • Zhen Tan

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: CORO1A associates inflammatory chondrocyte subsets with changes in the immune microenvironment in osteoarthritis: a comprehensive multi-omics and single-cell analysis

At a Glance

CategoryDetail
ConditionOsteoarthritis (OA)
Key MechanismsCORO1A expression in inflammatory chondrocytes linked to immune cell infiltration and signaling pathways (IL-6/JAK-STAT3, TNF-α/NF-κB)
Target PopulationIndividuals with osteoarthritis, particularly those with knee osteoarthritis (KOA)
Care SettingClinical and research settings focusing on osteoarthritis pathology

Key Highlights

  • CORO1A is significantly expressed in osteoarthritic cartilage, particularly in inflammatory chondrocyte subpopulations.
  • Increased CORO1A expression is associated with immune cell infiltration, including M2 macrophages and natural killer cells.
  • CORO1A regulates chondrocyte migration and MMP13 expression in response to inflammatory stimuli.
  • The study emphasizes the role of CORO1A in connecting immune remodeling to cartilage degradation.
  • Potential therapeutic target for osteoarthritis identified through its mechanistic role.

Guideline-Based Recommendations

Diagnosis

  • Assess the presence of inflammatory chondrocyte subsets in osteoarthritis.

Management

  • Consider targeting CORO1A for therapeutic interventions in osteoarthritis.

Monitoring & Follow-up

  • Monitor CORO1A expression levels as a potential biomarker for disease progression.

Risks

  • Increased CORO1A may correlate with enhanced immune activity and cartilage degradation.

Patient & Prescribing Data

Patients diagnosed with osteoarthritis, particularly those experiencing significant joint pain and mobility issues.

Current treatments primarily focus on symptom relief; understanding CORO1A's role may lead to novel therapeutic strategies.

Clinical Best Practices

  • Utilize multi-omics approaches to better understand the molecular mechanisms of osteoarthritis.
  • Incorporate single-cell analysis to identify specific chondrocyte populations and their roles in the immune microenvironment.
  • Evaluate the impact of immune cell interactions on cartilage health and disease progression.

Related Resources & Content

Original Source(s)

Related Content